SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001724741-18-000001
Filing Date
2018-12-14
Accepted
2018-12-14 10:03:49
Documents
1
Effectiveness Date
2018-12-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6559
  Complete submission text file 0001724741-18-000001.txt   7583
Mailing Address 146 CLIFFORD STREET PROVIDENCE RI 02903
Business Address 146 CLIFFORD STREET PROVIDENCE RI 02903 (401)272-2123
EpiVax Oncology, Inc. (Filer) CIK: 0001724741 (see all company filings)

IRS No.: 815453645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-300416 | Film No.: 181234756